Annovis Bio (NYSE:ANVS) Stock Rating Reaffirmed by HC Wainwright

Annovis Bio (NYSE:ANVS – Get Free Report)‘s stock had its “buy” rating reissued by stock analysts at HC Wainwright in a report released on Wednesday, Benzinga reports. They presently have a $23.00 price objective on the stock. HC Wainwright’s price target would suggest a potential upside of 282.70% from the stock’s previous close. Several other […]

Leave a Reply

Your email address will not be published.

Previous post Citigroup Trims Adobe (NASDAQ:ADBE) Target Price to $529.00
Next post Analysts Set O-I Glass, Inc. (NYSE:OI) PT at $19.56